Redmile Group, LLC's Form 4 filing
ADC Therapeutics SA (ADCT) · filed Jul 3, 2024
- Accession no.
- 0001104659-24-077865
- Filed
- Jul 3, 2024, 8:00 PM ET
- Trade date
- Jul 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Redmile Group, LLCCIK 0001425738 | 10% Owner |
| Green JeremyCIK 0001650527 | 10% Owner |
| RedCo II Master Fund, L.P.CIK 0001921783 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Shares, par value CHF 0.08 per share | PPurchaseAcquired | +400,000 | $2.81 | +$1,124,000 | 15,669,217 | Indirect | |
| Jul 1, 2024 | Common Shares, par value CHF 0.08 per share | PPurchaseAcquired | +400,000 | $2.81 | +$1,124,000 | 12,995,040 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.